BRAIN and NERVE－神経研究の進歩74巻7号

2022年07月発行

特集 COVID-19—脳神経内科医が診るための最新知識2022

—COVID-19神経合併症（2）—脳血管障害update

著者： 吉本武史¹ 豊田一則²

所属機関： ¹国立循環器病研究センター脳神経内科 ²国立循環器病研究センター脳血管内科

ページ範囲：P.853 - P.859

文献概要

いまだ世界中で猛威を振るっているCOVID-19の感染者数の増加に伴い，COVID-19関連神経学的合併症の報告が増加した。特にCOVID-19によって血栓形成促進状態が惹起され，脳梗塞発症リスクを高めることが示された。一方で，2022年において，COVID-19合併脳卒中の頻度が蔓延当初よりも少ないなど，蔓延当初の報告とやや異なる点も散見され始めている。本論では，COVID-19と脳卒中，特に脳梗塞との関連，COVID-19合併脳卒中の病態および予後について，最新の論文を参考に述べる。

参考文献

1）Chen N, Zhou M, Dong X, Qu J, Gong F, et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395: 507-513, 2020

2）Mahase E: Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ 368: m1036, 2020［doi: 10.1136/bmj.m1036］

3）Markus HS, Brainin M: COVID-19 and stroke-a global World Stroke Organization perspective. Int J Stroke 15: 361-364, 2020

4）Khosravain H, Rajendram P, Notario L, Chapman MG, Menon BK: Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke 51: 1891-1895, 2020

5）日本脳卒中学会, COVID-19対策プロジェクトチーム, JSS-PCS作成ワーキンググループ: COVID-19パンデミック下の脳卒中診療—Protected Code Stroke. 脳卒中 42: 315-343, 2020

6）Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, et al: Neurological associations of COVID-19. Lancet Neurol 19: 767-783, 2020

7）Helms J, Kremer S, Merdji H, Clere-Jehl R, Schencket M, et al: Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382: 2268-2270, 2020

8）Mao L, Jin H, Wang M, Hu Y, Chen S, et al: Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77: 683-690, 2020

9）World Health Organization: Clinical management of COVID-19: interim guidance, 27May 2020. https://apps.who.int/iris/handle/10665/332196（最終閲覧日: 2022年4月1日）

10）World Health Organization: COVID-19 clinical management: living guidance, 25 January 2021. https://apps.who.int/iris/handle/10665/338882（最終閲覧日: 2022年4月1日）

11）Elkind MSV: Why now? Moving from stroke risk factors to stroke triggers. Curr Opin Neurol 20: 51-57, 2007

12）Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, et al: Neurological associations of COVID-19. Lancet Neurol 19: 767-783, 2020

13）Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, et al: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203: 631-637, 2004

14）Moore HB, Barrett CD, Moore EE, McIntyre RC, Moore PK, et al: Is there a role for tissue plasminogen activator (tpa) as a novel treatment for refractory covid-19 associated acute respiratory distress syndrome (yards)? J Trauma Acute Care Surg 88: 713-714, 2020

15）Cui S, Chen S, Li X, Liu S, Wang F: Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18: 1421-1424, 2020

16）Chen G, Wu D, Guo W, Cao Y, Huang D, et al: Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130: 2620-2629, 2020

17）Li Y, Li M, Wang M, Zhou Y, Chang J, et al: Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5: 279-284, 2020

18）Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, et al: COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis 50: 587-595, 2020

19）Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, et al: Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382: e60, 2020［doi: 10.1056/NEJMc2009787］

20）Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, et al: Acute ischemic stroke and COVID-19: an analysis of 27 676 patients. Stroke 52: 905-912, 2021

21）Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, et al: Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 77: 1366-1372, 2020

22）Yaghi S, Ishida K, Torres J, Grory BM, Raz E, et al: SARS-CoV-2 and stroke in a New York healthcare system. Stroke 51: 2002-2011, 2020

23）Sluis WM, Linschoten M, Buijs JE, Biesbroek JM, den Hertog HM, et al: Risk, clinical course, and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study. Stroke 52: 3978-3986, 2021

24）Perry RJ, Smith CJ, Roffe C, Simister R, Narayanamoorthi S, et al: Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry 92: 242-248, 2021

25）Kihira S, Schefflein J, Mahmoudi K, Rigney B, Delman BN, et al: Association of Coronavirus Disease (COVID-19) With Large Vessel Occlusion Strokes: A Case-Control Study. Am J Roentgenol 216: 150-156, 2021

26）Shahjouei S, Tsivgoulis G, Farahmand G, Koza E, Mowla A, et al: SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group. Stroke 52: e117-e130, 2021

27）O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112-123, 2010

28）Al-Rukn S, Mazya M, Hentati F, Sassi SB, Nabli F, et al: Stroke in the Middle-East and North Africa: a 2-year prospective observational study of stroke characteristics in the region-results from the Safe Implementation of Treatments in Stroke (SITS)-Middle-East and North African (MENA). Int J Stroke 14: 715-722, 2019

29）Paci M, Nannetti L, D'Ippolito P, Lombardi B: Outcomes from ischemic stroke subtypes classified by the Oxfordshire Community Stroke Project: a systematic review. Eur J Phys Rehabil Med 47: 19-23, 2011

30）Nogueira RG, Abdalkader M, Qureshi MM, Frankel MR, Mansour OY, et al: Global impact of COVID-19 on stroke care. Int J Stroke 16: 573-584, 2021

31）Kerleroux B, Fabacher T, Bricout N, Moïse M, Testud B, et al: Mechanical thrombectomy for acute ischemic stroke amid the COVID-19 outbreak: decreased activity, and increased care delays. Stroke 51: 2012-2017, 2020

32）Kansagra AP, Goyal MS, Hamilton S, Albers GW: Collateral effect of Covid-19 on stroke evaluation in the United States. N Engl J Med 383: 400-401, 2020

33）Walker PGT, Whittaker C, Watson OJ, Baguelin M, Winskill P, et al: The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science 369: 413-422, 2020

34）Nogueira RG, Qureshi MM, Abdalkader M, Martins SO, Yamagami H, et al: Global impact of COVID-19 on stroke care and intravenous thrombolysis. Neurology 96: e2824-e2838, 2021

35）Pandian JD, Panagos PD, Sebastian IA, Silva GS, Furie KL, et al: Maintaining stroke care during the COVID-19 pandemic in lower- and middle-income countries: World Stroke Organization Position Statement endorsed by American Stroke Association and American Heart Association. Int J Stroke 17: 9-17, 2022

36）Teo KC, Leung WC, Wong YK, Liu RKC, Chan AHY, et al: Delays in stroke onset to hospital arrival time during COVID-19. Stroke 51: 2228-2231, 2020

37）Meza HT, Gil AL, Saldana AS, Yus CV, Barón BP, et al: Ischaemic stroke in the time of coronavirus disease 2019. Eur J Neurol 27: 1788-1792, 2020

38）Srivastava PK, Zhang S, Xian Y, Hanzhang Xu H, Rutan C, et al: Acute ischemic stroke in patients with COVID-19: an analysis from get with the guidelines-stroke. Stroke 52: 1826-1829, 2021

39）Ohara N, Imamura H, Adachi H, Hara Y, Hosoda K, et al: Stroke systems of care during the COVID-19 epidemic in Kobe City. J Stroke Cerebrovasc Dis 29: 105343, 2020［doi: 10.1016/j.strokecerebrovasdis.2020.105343］

40）Koge J, Shiozawa M, Toyoda K: Acute stroke care in the with-COVID-19 era: experience at a comprehensive stroke center in Japan. Front Neurol 11: 611504, 2021［doi: 10/3389/fneur.2020.611504］

41）Yoshimoto T, Shiozawa M, Koge J, Inoue M, Koga M, et al: Evaluation of workflow delays in stroke reperfusion therapy: a comparison between the year-long pre-COVID-19 period: and the with-COVID-19 period. J Atheroscler Thromb 2021 Aug 13. [Online ahead of print]［doi: 10.5551/jat.63090］

42）O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, et al: Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 388: 761-775, 2016

43）Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, et al: Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 91: 889-891, 2020

44）Gunes HN, Cokal BG, Guler SK, Yoldas TK, Malkan UY, et al: Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis. J Int Med Res 44: 1454-1461, 2016

45）Zuurbier SM, Middeldorp S, Stam J, Coutinho JM: Sex differences in cerebral venous thrombosis: a systematic analysis of a shift over time. Int J Stroke 11: 164-170, 2016

46）Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, et al: Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 10: 1297-1302, 2012

47）Coutinho JM, Zuurbier SM, Aramideh M, Stam J: The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 43: 3375-3377, 2012

48）Sidhom Y, Mansour M, Messelmani M, Derbali H, Fekih-Mrissa N, et al: Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort. J Stroke Cerebrovasc Dis 23: 1291-1295, 2014

49）Ferro JM, Aguiar de Sousa D: Cerebral venous thrombosis: an update. Curr Neurol Neurosci Rep 19: 74, 2019［doi: 10.1007/s11910-019-0988-x］